Patient Centered Care through eHealth Solutions
- Conditions
- COPD
- Registration Number
- NL-OMON21897
- Lead Sponsor
- eiden University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 700
Inclusion Criteria
primary care COPD-patients with chronic respiratory symptoms and post-bronchodilator FEV1/FVC<0.7, in accordance with the international GOLD-classification 30 and the Dutch GPs COPD Guidelines .
Exclusion Criteria
- patients who are unable to fill in questionnaires
- patients that have no access to internet
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the primary objective of this study is to investigate clinical effects of different implementation methods of online supported self-management for COPD patients in primary care.
- Secondary Outcome Measures
Name Time Method The secondary objectives are to investigate the effects of different implementation methods on well-being, health care use and actual use of the online patient portal.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does the eVita COPD eHealth intervention modulate inflammatory pathways in patients with chronic obstructive pulmonary disease (COPD)?
What is the comparative effectiveness of eHealth solutions versus standard pulmonary rehabilitation in improving FEV1 and quality of life for COPD patients?
Which biomarkers, such as IL-6 or TNF-alpha, predict response to eHealth-based patient-centered care in COPD subtypes like emphysema or chronic bronchitis?
What are the known adverse events and management strategies for eHealth interventions in COPD management, particularly regarding user engagement and data security?
How does the eVita COPD trial's eHealth approach compare to other digital health platforms in targeting exacerbation frequency and medication adherence in COPD?